Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: COMBINATION_PRODUCT: Palliative Radiation and Pembrolizumab
Sponsor: University of Louisville
Collaborators: James Graham Brown Cancer Center